Distigmine (Br) Overview Categories 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Reteplase Manufacturers of Reteplase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Reteplase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 to 20 mg12 (12.5)24 hourlyIMBefore break fact (increased at internals of 3-4 days)0.5 mg0.5 (0.5)24 hourlyIMPercentral (24 to 72 hours after surgury and repeated at intervals of 1 to 3 days) Paedriatic Dosage (20kg) 10 mg10 (10)As recommended.daily Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Reteplase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Reteplase Back to top Manufacturers of Distigmine (Br) in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Distigmine (Br) Overview Categories 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Reteplase Manufacturers of Reteplase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Reteplase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 to 20 mg12 (12.5)24 hourlyIMBefore break fact (increased at internals of 3-4 days)0.5 mg0.5 (0.5)24 hourlyIMPercentral (24 to 72 hours after surgury and repeated at intervals of 1 to 3 days) Paedriatic Dosage (20kg) 10 mg10 (10)As recommended.daily Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Reteplase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Reteplase Back to top Manufacturers of Distigmine (Br) in Pakistan Back to top Previous Drug Generic - Next Drug Generic